Literature DB >> 23105704

Xanthelasma Palpebrarum-clinical and biochemical profile in a tertiary care hospital of Delhi.

A Jain1, P Goyal, P K Nigam, H Gurbaksh, R C Sharma.   

Abstract

Xanthelasma Palpebrarum is the most common of the xanthomas with asymptomatic, symmetrical, bilateral, soft, yellow, velvety, polygonal papules around the eyelids. Xanthelasmas may be associated with hyperlipidemia. This prospective study included 66 clinically diagnosed patients with Xanthelasma Palpebrarum and 50 controls with non-inflammatory skin disorders. Serum triglyceride, cholesterol, HDL, LDL and VLDL estimated in all cases indicated that patients with Xanthelasma Palpebrarum have underlying lipid abnormalities.

Entities:  

Keywords:  Hyperlipidemia; Lipids; Xanthelasma Palpebrarum

Year:  2007        PMID： 23105704      PMCID： PMC3453794          DOI： 10.1007/BF02913335

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN： 0970-1915


  16 in total

1.  XANTHELASMA PALPEBRARUM.

Authors:  F J PEDACE; R K WINKELMANN
Journal:  JAMA       Date:  1965-09-13       Impact factor: 56.272

2.  Clinical observations regarding xanthelasma.

Authors:  J B VACCA; W A KNIGHT; G O BROUN
Journal:  Ann Intern Med       Date:  1959-11       Impact factor: 25.391

3.  Xanthelasma and hyperlipoproteinaemia.

Authors:  F D Dean
Journal:  Clin Chim Acta       Date:  1976-01-16       Impact factor: 3.786

4.  Normolipidemic xanthelasma palpebrarum: lipid composition, cholesterol metabolism in monocyte-derived macrophages, and plasma lipid peroxidation.

Authors:  R Bergman; Y Kasif; M Aviram; I Maor; Y Ullman; M Gdal-On; R Friedman-Birnbaum
Journal:  Acta Derm Venereol       Date:  1996-03       Impact factor: 4.437

5.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

6.  Quantitative determination of serum triglycerides by the use of enzymes.

Authors:  G Bucolo; H David
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

7.  Xanthelasma palpebrarum: an analysis of 141 cases.

Authors:  M K Chhetri; N D Chowdhury; B De
Journal:  J Assoc Physicians India       Date:  1967-09

8.  Letter: Significance of xanthelasma palpebrarum in the normal population.

Authors:  A Jónsson; N Sigfŭsson
Journal:  Lancet       Date:  1976-02-14       Impact factor: 79.321

9.  The association of dyslipoproteinemia with corneal arcus and xanthelasma. The Lipid Research Clinics Program Prevalence Study.

Authors:  P Segal; W Insull; L E Chambless; S Stinnett; J C LaRosa; L Weissfeld; S Halfon; P O Kwiterovitch; J A Little
Journal:  Circulation       Date:  1986-01       Impact factor: 29.690

10.  Serum lipids, lipoprotein lipids and coronary heart disease in patients with xanthelasma palpebrarum.

Authors:  A Watanabe; A Yoshimura; T Wakasugi; R Tatami; K Ueda; R Ueda; T Haba; T Kametani; J Koizumi; S Ito; M Ohta; S Miyamoto; H Mabuchi; R Takeda
Journal:  Atherosclerosis       Date:  1981 Feb-Mar       Impact factor: 5.162
View more
  11 in total

1.  Bilateral extensive nodular xanthelasma palpebrarum: an infrequent case report.

Authors:  Pei Wang; Qingli Luo; Li Tang
Journal:  Int Ophthalmol       Date:  2017-04-03       Impact factor: 2.031

2.  Periorbital Hyperpigmentation in Patients with Xanthelasma Palpebrarum: An Interesting Observation.

Authors:  Eftychia Platsidaki; Anargyros Kouris; Efthymia Agiasofitou; Christina Antoniou; Georgios Kontochristopoulos
Journal:  J Clin Aesthet Dermatol       Date:  2016-04-01

3.  Serum lipid profile and clinical characteristics of patients with xanthelasma palpebrarum.

Authors:  Hossein Kavoussi; Ali Ebrahimi; Mansour Rezaei; Mazaher Ramezani; Behnaz Najafi; Reza Kavoussi
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

4.  Diet in dermatology: present perspectives.

Authors:  K H Basavaraj; C Seemanthini; R Rashmi
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

5.  Xanthelasma palpebrarum associated with increased cardio-ankle vascular index in asymptomatic subjects.

Authors:  Ali Rıza Akyüz; Turhan Turan; Musluhittin Emre Erkuş; İsmail Gürbak; Selim Kul; Levent Korkmaz; Mustafa Tarık Ağaç; Şükrü Çelik
Journal:  Wien Klin Wochenschr       Date:  2016-03-14       Impact factor: 1.704

6.  Familial xanthelasma with dyslipidemia: just another family trait?

Authors:  Shridhar Dwivedi; Amitesh Aggarwal; Safal Singh; Vishal Sharma
Journal:  N Am J Med Sci       Date:  2012-05

7.  Xanthelasma Is Associated with an Increased Amount of Epicardial Adipose Tissue.

Authors:  Ali Rıza Akyüz; Mustafa Tarık Ağaç; Turhan Turan; Sinan Şahin; Selim Kul; Levent Korkmaz; Musluhittin Emre Erkuş; Hakan Erkan; Şükrü Çelik
Journal:  Med Princ Pract       Date:  2015-10-21       Impact factor: 1.927

8.  Comparative Study to Evaluate the Efficacy of Radiofrequency Ablation versus Trichloroacetic Acid in the Treatment of Xanthelasma Palpebrarum.

Authors:  Praveen Kumar Shanmugam Reddy; Sumathy Tharayil Kunneth; Shyam Prasad Arakali Lakshminarayana; Suparna Madivalara Yallappa; Ranganathan Chandrashekara; Shivaswamy Kanakapura Nanjundaswamy
Journal:  J Cutan Aesthet Surg       Date:  2016 Oct-Dec

9.  Cardiovascular profile of xanthelasma palpebrarum.

Authors:  Anupam Dey; Ramesh Aggarwal; Shridhar Dwivedi
Journal:  Biomed Res Int       Date:  2013-06-20       Impact factor: 3.411

10.  Xanthelasma Palpebrarum with Arcus Cornea: A Clinical and Biochemical Study.

Authors:  Pragya Ashok Nair; Chaitali R Patel; Jaishree D Ganjiwale; Nilofar Gulamsha Diwan; Nidhi Bhimjibhai Jivani
Journal:  Indian J Dermatol       Date:  2016 May-Jun       Impact factor: 1.494
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.